G protein-coupled estrogen receptor (GPER) mediates NSCLC progression induced by 17β-estradiol (E2) and selective agonist G1

Lack of G protein-coupled estrogen receptor (GPER) in the plasma membrane is associated with excellent long-term prognosis in breast cancer

(2014) Martin Sjöström et al.   BREAST CANCER RESEARCH AND TREATMENT

Cancer statistics, 2014

(2014) Rebecca Siegel et al.   CA-A CANCER JOURNAL FOR CLINICIANS

The Correlation between GPR30 and Clinicopathologic Variables in Breast Carcinomas

(2014) Gang Tu et al.   TECHNOLOGY IN CANCER RESEARCH & TREATMENT

Estrogen and insulin-like growth factor 1 synergistically promote the development of lung adenocarcinoma in mice

(2013) Hexiao Tang et al.   INTERNATIONAL JOURNAL OF CANCER

Antiestrogen Fulvestrant Enhances the Antiproliferative Effects of Epidermal Growth Factor Receptor Inhibitors in Human Non–Small-Cell Lung Cancer

(2013) Edward B. Garon et al.   Journal of Thoracic Oncology

Estrogenic Steroid Hormones in Lung Cancer

(2013) Jill M. Siegfried et al.   SEMINARS IN ONCOLOGY

The G protein-coupled receptor GPR30 mediates the proliferative and invasive effects induced by hydroxytamoxifen in endometrial cancer cells

(2012) Gui-Qiang Du et al.   BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS

Enhanced expression of G-protein coupled estrogen receptor (GPER/GPR30) in lung cancer

(2012) Venkatakrishna Rao Jala et al.   BMC CANCER

Inactivation of GPR30 reduces growth of triple-negative breast cancer cells: possible application in targeted therapy

(2012) Rainer Girgert et al.   BREAST CANCER RESEARCH AND TREATMENT

Estrogen upregulates the IGF-1 signaling pathway in lung cancer through estrogen receptor-β

(2012) Hexiao Tang et al.   MEDICAL ONCOLOGY

Lung cancer mortality risk among breast cancer patients treated with anti-estrogens

(2011) Christine Bouchardy et al.   CANCER

The G-protein-coupled estrogen receptor GPER in health and disease

(2011) Eric R. Prossnitz et al.   Nature Reviews Endocrinology

Lung Cancer and Hormone Replacement Therapy: Association in the Vitamins and Lifestyle Study

(2010) Christopher G. Slatore et al.   JOURNAL OF CLINICAL ONCOLOGY

Stimulating the GPR30 Estrogen Receptor with a Novel Tamoxifen Analogue Activates SF-1 and Promotes Endometrial Cell Proliferation

(2009) Benjamin C. Lin et al.   CANCER RESEARCH

Estrogenic GPR30 signalling induces proliferation and migration of breast cancer cells through CTGF

(2009) Deo Prakash Pandey et al.   EMBO JOURNAL

GPR30 predicts poor survival for ovarian cancer

(2009) Harriet O. Smith et al.   GYNECOLOGIC ONCOLOGY

Beneficial role of the GPR30 agonist G-1 in an animal model of multiple sclerosis

(2009) Eric Blasko et al.   JOURNAL OF NEUROIMMUNOLOGY

Estrogen receptor beta (ERβ) subtype-specific ligands increase transcription, p44/p42 mitogen activated protein kinase (MAPK) activation and growth in human non-small cell lung cancer cells

(2009) Pamela A. Hershberger et al.   JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY

Oestrogen plus progestin and lung cancer in postmenopausal women (Women's Health Initiative trial): a post-hoc analysis of a randomised controlled trial

(2009) Rowan T Chlebowski et al.   LANCET

Estrogen Receptor β Functions through Nongenomic Mechanisms in Lung Cancer Cells

(2008) GuangFeng Zhang et al.   MOLECULAR ENDOCRINOLOGY